Mild chronic hypertension (or high blood pressure) is a common condition that affects about 2% of all pregnancies in the United States. Women entering pregnancy with high blood pressure (hypertension) are at increased risk for developing preeclampsia and having a preterm birth. Considering these risks, some healthcare providers may recommend early planned delivery (on or after 37 weeks) to try to prevent developing preeclampsia. However, planned delivery before 39 weeks can be associated with increased risks for the baby.
In this study, researchers asked what is the best time to deliver babies for pregnant individuals with mild, pre-pregnancy hypertension to improve health outcomes. The study included over 1,400 participants who were either newly diagnosed or had a history of hypertension, and excluded cases with severe conditions like preeclampsia before 37 weeks. The study compared planned deliveries (inducing labor) and waiting for natural labor at each week of pregnancy. The study found that planned early delivery was not associated with a reduction in adverse maternal outcomes. However, it was associated with increased odds of some neonatal complications such as neonatal intensive care unit admission, respiratory distress syndrome (RDS), transient tachypnea of the newborn (fluid in the lungs), and hypoglycemia (low blood sugar). Delivering at 37 or 38 weeks did not improve serious maternal or neonatal outcomes (including the development of preeclampsia) but delivering early did increase the risk of breathing issues and low blood sugar in babies.
Current American College of Obstetricians and Gynecologists (ACOG) guidelines recommend delivery as early as 37 0/7 weeks of gestation to as late as 39 6/7 weeks for mild chronic hypertension. In a more complex pregnancy or case of preeclampsia with severe features, induction of labor is often recommended earlier than 39 weeks of gestation because the risks associated with ongoing pregnancy are greater than the risks of early-term delivery. More research is needed in order to enhance or change clinical guidelines.
Take Home: The key takeaway is for pregnant individuals with mild chronic hypertension, planning to deliver before 39 weeks does not significantly improve maternal health outcomes and may increase the risk of complications in newborns, such as breathing problems and low blood sugar.
In conclusion, waiting for a planned delivery until 39 weeks of gestation, while considering the overall clinical situation and the potential need for earlier delivery when necessary, may improve outcomes for both mothers and newborns in individuals with mild chronic hypertension. Always follow the guidance of your healthcare provider or maternal fetal medicine specialist on the best time to deliver your baby.
Your story is needed to improve outcomes for moms like you. Add your voice to critical preeclampsia research to ensure that every story is heard.
Frequently asked questions about the Preeclampsia Registry, a patient-driven registry and biobank.
The Preeclampsia Foundation offers research funding, study recruitment, and other patient engagement services to researchers.
We provide research grant funding to advance progress towards detection, prevention, or treatment of preeclampsia, HELLP syndrome, and other hypertensive disorders of pregnancy.
Hypertensive disorders of pregnancy significantly increase your risk of developing long-term heart problems. A careful review of blood pressure elevations during and after pregnancy may assist in iden...
Hypertensive disorders of pregnancy (HDP) can affect different groups of women in different ways, and even though we know this happening, we don't fully understand why. There are many factors, like bi...
There is growing evidence that studies examining pregnancy and its complications need to start early within the pregnancy to fully understand the nature of preeclampsia. Key gestational milestones, wh...
It is known that chronic hypertension and high BMI (body mass index) are risk factors for hypertensive disorders of pregnancy (HDP). Studies documenting this risk have usually assessed blood pre...
Several biomarker tests are under development to predict or diagnose preeclampsia. While none of these tests are yet widely accepted in U.S. clinical practice, two FDA-approved tests are available in...
